ID   RPC2_HUMAN              Reviewed;        1133 AA.
AC   Q9NW08; A8K6H0; B3KV73; F5H1E6; Q9NW59;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2003, sequence version 2.
DT   12-APR-2017, entry version 152.
DE   RecName: Full=DNA-directed RNA polymerase III subunit RPC2;
DE            Short=RNA polymerase III subunit C2;
DE            EC=2.7.7.6;
DE   AltName: Full=C128;
DE   AltName: Full=DNA-directed RNA polymerase III 127.6 kDa polypeptide;
DE   AltName: Full=DNA-directed RNA polymerase III subunit B;
GN   Name=POLR3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION IN THE RNA POL
RP   III COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12391170; DOI=10.1128/MCB.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P.,
RA   Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues
RT   for Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, Teratocarcinoma, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=19631370; DOI=10.1016/j.cell.2009.06.015;
RA   Chiu Y.-H., Macmillan J.B., Chen Z.J.;
RT   "RNA polymerase III detects cytosolic DNA and induces type I
RT   interferons through the RIG-I pathway.";
RL   Cell 138:576-591(2009).
RN   [7]
RP   FUNCTION.
RX   PubMed=19609254; DOI=10.1038/ni.1779;
RA   Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A.,
RA   Hornung V.;
RT   "RIG-I-dependent sensing of poly(dA:dT) through the induction of an
RT   RNA polymerase III-transcribed RNA intermediate.";
RL   Nat. Immunol. 10:1065-1072(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [10]
RP   VARIANTS HLD8 620-ASN--LYS-652 DEL; HIS-768 AND GLU-926, AND
RP   INVOLVEMENT IN HLD8.
RX   PubMed=22036171; DOI=10.1016/j.ajhg.2011.10.003;
RA   Saitsu H., Osaka H., Sasaki M., Takanashi J., Hamada K., Yamashita A.,
RA   Shibayama H., Shiina M., Kondo Y., Nishiyama K., Tsurusaki Y.,
RA   Miyake N., Doi H., Ogata K., Inoue K., Matsumoto N.;
RT   "Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits
RT   cause an autosomal-recessive hypomyelinating leukoencephalopathy.";
RL   Am. J. Hum. Genet. 89:644-651(2011).
RN   [11]
RP   VARIANTS HLD8 LYS-503 AND GLU-523.
RX   PubMed=22036172; DOI=10.1016/j.ajhg.2011.10.006;
RA   Tetreault M., Choquet K., Orcesi S., Tonduti D., Balottin U.,
RA   Teichmann M., Fribourg S., Schiffmann R., Brais B., Vanderver A.,
RA   Bernard G.;
RT   "Recessive mutations in POLR3B, encoding the second largest subunit of
RT   Pol III, cause a rare hypomyelinating leukodystrophy.";
RL   Am. J. Hum. Genet. 89:652-655(2011).
RN   [12]
RP   VARIANTS HLD8 PHE-104; GLY-268; CYS-442; GLU-523 AND ARG-527.
RX   PubMed=23355746; DOI=10.1136/jmedgenet-2012-101357;
RA   Daoud H., Tetreault M., Gibson W., Guerrero K., Cohen A.,
RA   Gburek-Augustat J., Synofzik M., Brais B., Stevens C.A.,
RA   Sanchez-Carpintero R., Goizet C., Naidu S., Vanderver A., Bernard G.;
RT   "Mutations in POLR3A and POLR3B are a major cause of hypomyelinating
RT   leukodystrophies with or without dental abnormalities and/or
RT   hypogonadotropic hypogonadism.";
RL   J. Med. Genet. 50:194-197(2013).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Second largest core component of RNA polymerase III
CC       which synthesizes small RNAs, such as 5S rRNA and tRNAs. Proposed
CC       to contribute to the polymerase catalytic activity and forms the
CC       polymerase active center together with the largest subunit. Pol
CC       III is composed of mobile elements and RPC2 is part of the core
CC       element with the central large cleft and probably a clamp element
CC       that moves to open and close the cleft (By similarity). Plays a
CC       key role in sensing and limiting infection by intracellular
CC       bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor
CC       involved in innate immune response. Can sense non-self dsDNA that
CC       serves as template for transcription into dsRNA. The non-self RNA
CC       polymerase III transcripts, such as Epstein-Barr virus-encoded
CC       RNAs (EBERs) induce type I interferon and NF- Kappa-B through the
CC       RIG-I pathway. {ECO:0000250, ECO:0000269|PubMed:19609254,
CC       ECO:0000269|PubMed:19631370}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1).
CC   -!- SUBUNIT: Component of the RNA polymerase III (Pol III) complex
CC       consisting of 17 subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NW08-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NW08-2; Sequence=VSP_045286;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 8, with or without
CC       oligodontia and/or hypogonadotropic hypogonadism (HLD8)
CC       [MIM:614381]: An autosomal recessive neurodegenerative disorder
CC       characterized by early childhood onset of cerebellar ataxia and
CC       mild intellectual disabilities associated with diffuse
CC       hypomyelination apparent on brain MRI. Variable features include
CC       oligodontia and/or hypogonadotropic hypogonadism.
CC       {ECO:0000269|PubMed:22036171, ECO:0000269|PubMed:22036172,
CC       ECO:0000269|PubMed:23355746}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the RNA polymerase beta chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91527.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA91581.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY092084; AAM18214.1; -; mRNA.
DR   EMBL; AK001161; BAA91527.1; ALT_INIT; mRNA.
DR   EMBL; AK001250; BAA91581.1; ALT_INIT; mRNA.
DR   EMBL; AK122713; BAG53685.1; -; mRNA.
DR   EMBL; AK291635; BAF84324.1; -; mRNA.
DR   EMBL; AC009721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078992; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC080012; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97780.1; -; Genomic_DNA.
DR   EMBL; BC046238; AAH46238.1; -; mRNA.
DR   CCDS; CCDS53824.1; -. [Q9NW08-2]
DR   CCDS; CCDS9105.1; -. [Q9NW08-1]
DR   RefSeq; NP_001154180.1; NM_001160708.1. [Q9NW08-2]
DR   RefSeq; NP_060552.4; NM_018082.5. [Q9NW08-1]
DR   UniGene; Hs.610795; -.
DR   UniGene; Hs.62696; -.
DR   ProteinModelPortal; Q9NW08; -.
DR   BioGrid; 120828; 50.
DR   IntAct; Q9NW08; 10.
DR   STRING; 9606.ENSP00000228347; -.
DR   iPTMnet; Q9NW08; -.
DR   PhosphoSitePlus; Q9NW08; -.
DR   BioMuta; POLR3B; -.
DR   DMDM; 29428029; -.
DR   EPD; Q9NW08; -.
DR   MaxQB; Q9NW08; -.
DR   PaxDb; Q9NW08; -.
DR   PeptideAtlas; Q9NW08; -.
DR   PRIDE; Q9NW08; -.
DR   Ensembl; ENST00000228347; ENSP00000228347; ENSG00000013503. [Q9NW08-1]
DR   Ensembl; ENST00000539066; ENSP00000445721; ENSG00000013503. [Q9NW08-2]
DR   GeneID; 55703; -.
DR   KEGG; hsa:55703; -.
DR   UCSC; uc001tlp.3; human. [Q9NW08-1]
DR   CTD; 55703; -.
DR   DisGeNET; 55703; -.
DR   GeneCards; POLR3B; -.
DR   GeneReviews; POLR3B; -.
DR   H-InvDB; HIX0037055; -.
DR   HGNC; HGNC:30348; POLR3B.
DR   HPA; HPA036466; -.
DR   MalaCards; POLR3B; -.
DR   MIM; 614366; gene.
DR   MIM; 614381; phenotype.
DR   neXtProt; NX_Q9NW08; -.
DR   OpenTargets; ENSG00000013503; -.
DR   Orphanet; 88637; Hypomyelination - hypogonadotropic hypogonadism - hypodontia.
DR   PharmGKB; PA134867680; -.
DR   eggNOG; KOG0215; Eukaryota.
DR   eggNOG; COG0085; LUCA.
DR   GeneTree; ENSGT00860000133818; -.
DR   HOGENOM; HOG000222962; -.
DR   HOVERGEN; HBG017744; -.
DR   InParanoid; Q9NW08; -.
DR   KO; K03021; -.
DR   OMA; PYIIVKN; -.
DR   OrthoDB; EOG091G00PZ; -.
DR   PhylomeDB; Q9NW08; -.
DR   TreeFam; TF103047; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   ChiTaRS; POLR3B; human.
DR   GenomeRNAi; 55703; -.
DR   PRO; PR:Q9NW08; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000013503; -.
DR   CleanEx; HS_POLR3B; -.
DR   ExpressionAtlas; Q9NW08; baseline and differential.
DR   Genevisible; Q9NW08; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005666; C:DNA-directed RNA polymerase III complex; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032549; F:ribonucleoside binding; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IEA:GOC.
DR   CDD; cd00653; RNA_pol_B_RPB2; 1.
DR   Gene3D; 2.40.270.10; -; 1.
DR   Gene3D; 3.90.1110.10; -; 1.
DR   InterPro; IPR015712; DNA-dir_RNA_pol_su2.
DR   InterPro; IPR007120; DNA-dir_RNA_pol_su2_6.
DR   InterPro; IPR007121; RNA_pol_bsu_CS.
DR   InterPro; IPR007644; RNA_pol_bsu_protrusion.
DR   InterPro; IPR007642; RNA_pol_Rpb2_2.
DR   InterPro; IPR007645; RNA_pol_Rpb2_3.
DR   InterPro; IPR007646; RNA_pol_Rpb2_4.
DR   InterPro; IPR007647; RNA_pol_Rpb2_5.
DR   InterPro; IPR007641; RNA_pol_Rpb2_7.
DR   PANTHER; PTHR20856; PTHR20856; 1.
DR   Pfam; PF04563; RNA_pol_Rpb2_1; 1.
DR   Pfam; PF04561; RNA_pol_Rpb2_2; 1.
DR   Pfam; PF04565; RNA_pol_Rpb2_3; 1.
DR   Pfam; PF04566; RNA_pol_Rpb2_4; 1.
DR   Pfam; PF04567; RNA_pol_Rpb2_5; 1.
DR   Pfam; PF00562; RNA_pol_Rpb2_6; 1.
DR   Pfam; PF04560; RNA_pol_Rpb2_7; 1.
DR   PROSITE; PS01166; RNA_POL_BETA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Complete proteome;
KW   Disease mutation; DNA-directed RNA polymerase; Immunity;
KW   Innate immunity; Leukodystrophy; Metal-binding;
KW   Nucleotidyltransferase; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1   1133       DNA-directed RNA polymerase III subunit
FT                                RPC2.
FT                                /FTId=PRO_0000048092.
FT   ZN_FING    1080   1095       C4-type.
FT   METAL      1080   1080       Zinc. {ECO:0000250}.
FT   METAL      1083   1083       Zinc. {ECO:0000250}.
FT   METAL      1092   1092       Zinc. {ECO:0000250}.
FT   METAL      1095   1095       Zinc. {ECO:0000250}.
FT   VAR_SEQ       1     58       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045286.
FT   VARIANT     104    104       L -> F (in HLD8).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072344.
FT   VARIANT     268    268       S -> G (in HLD8).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072345.
FT   VARIANT     442    442       R -> C (in HLD8).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072346.
FT   VARIANT     503    503       T -> K (in HLD8; dbSNP:rs267608683).
FT                                {ECO:0000269|PubMed:22036172}.
FT                                /FTId=VAR_067005.
FT   VARIANT     523    523       V -> E (in HLD8; dbSNP:rs138249161).
FT                                {ECO:0000269|PubMed:22036172,
FT                                ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_067006.
FT   VARIANT     527    527       C -> R (in HLD8).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072347.
FT   VARIANT     620    652       Missing (in HLD8).
FT                                {ECO:0000269|PubMed:22036171}.
FT                                /FTId=VAR_067007.
FT   VARIANT     740    740       T -> A (in dbSNP:rs17038460).
FT                                /FTId=VAR_057255.
FT   VARIANT     768    768       R -> H (in HLD8; dbSNP:rs267608687).
FT                                {ECO:0000269|PubMed:22036171}.
FT                                /FTId=VAR_067008.
FT   VARIANT     926    926       D -> E (in HLD8; dbSNP:rs267608689).
FT                                {ECO:0000269|PubMed:22036171}.
FT                                /FTId=VAR_067009.
FT   CONFLICT    258    258       E -> A (in Ref. 1; AAM18214).
FT                                {ECO:0000305}.
FT   CONFLICT    607    607       T -> I (in Ref. 2; BAG53685).
FT                                {ECO:0000305}.
FT   CONFLICT    978    978       R -> C (in Ref. 2; BAA91527).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1133 AA;  127785 MW;  F0B3AFF892DDED7D CRC64;
     MDVLAEEFGN LTPEQLAAPI PTVEEKWRLL PAFLKVKGLV KQHIDSFNYF INVEIKKIMK
     ANEKVTSDAD PMWYLKYLNI YVGLPDVEES FNVTRPVSPH ECRLRDMTYS APITVDIEYT
     RGSQRIIRNA LPIGRMPIML RSSNCVLTGK TPAEFAKLNE CPLDPGGYFI VKGVEKVILI
     QEQLSKNRII VEADRKGAVG ASVTSSTHEK KSRTNMAVKQ GRFYLRHNTL SEDIPIVIIF
     KAMGVESDQE IVQMIGTEEH VMAAFGPSLE ECQKAQIFTQ MQALKYIGNK VRRQRMWGGG
     PKKTKIEEAR ELLASTILTH VPVKEFNFRA KCIYTAVMVR RVILAQGDNK VDDRDYYGNK
     RLELAGQLLS LLFEDLFKKF NSEMKKIADQ VIPKQRAAQF DVVKHMRQDQ ITNGMVNAIS
     TGNWSLKRFK MDRQGVTQVL SRLSYISALG MMTRISSQFE KTRKVSGPRS LQPSQWGMLC
     PSDTPEGEAC GLVKNLALMT HITTDMEDGP IVKLASNLGV EDVNLLCGEE LSYPNVFLVF
     LNGNILGVIR DHKKLVNTFR LMRRAGYINE FVSISTNLTD RCVYISSDGG RLCRPYIIVK
     KQKPAVTNKH MEELAQGYRN FEDFLHESLV EYLDVNEEND CNIALYEHTI NKDTTHLEIE
     PFTLLGVCAG LIPYPHHNQS PRNTYQCAMG KQAMGTIGYN QRNRIDTLMY LLAYPQKPMV
     KTKTIELIEF EKLPAGQNAT VAVMSYSGYD IEDALVLNKA SLDRGFGRCL VYKNAKCTLK
     RYTNQTFDKV MGPMLDAATR KPIWRHEILD ADGICSPGEK VENKQVLVNK SMPTVTQIPL
     EGSNVPQQPQ YKDVPITYKG ATDSYIEKVM ISSNAEDAFL IKMLLRQTRR PEIGDKFSSR
     HGQKGVCGLI VPQEDMPFCD SGICPDIIMN PHGFPSRMTV GKLIELLAGK AGVLDGRFHY
     GTAFGGSKVK DVCEDLVRHG YNYLGKDYVT SGITGEPLEA YIYFGPVYYQ KLKHMVLDKM
     HARARGPRAV LTRQPTEGRS RDGGLRLGEM ERDCLIGYGA SMLLLERLMI SSDAFEVDVC
     GQCGLLGYSG WCHYCKSSCH VSSLRIPYAC KLLFQELQSM NIIPRLKLSK YNE
//
